Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

ADVANCED DIAGNOSTIC LABS INC

NPI: 1326451972 · PHOENIX, AZ 85027 · Clinical Medical Laboratory · NPI assigned 06/10/2014

$105K
Total Medicaid Paid
3,927
Total Claims
2,949
Beneficiary Records
17
Codes Billed
2018-01
First Month
2019-07
Last Month

Provider Details

Authorized OfficialMANSOR, THOMAS (OWNER / PRESIDENT)
NPI Enumeration Date06/10/2014

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 2,010 $40K
2019 1,917 $64K

Billing Codes

CodeDescriptionClaimsBene. RecordsTotal Paid
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 2,299 1,504 $91K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1,374 1,191 $14K
80373 16 16 $4.19
80367 16 16 $4.19
80370 16 16 $3.66
80348 16 16 $0.00
80356 16 16 $0.00
80365 16 16 $0.00
80361 16 16 $0.00
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 30 30 $0.00
80346 16 16 $0.00
80354 16 16 $0.00
80363 16 16 $0.00
80358 16 16 $0.00
80353 16 16 $0.00
80324 16 16 $0.00
80359 16 16 $0.00